Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Instagram Outage Disrupts Thousands of U.S. Users 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
NEW YORK, Oct. 14, 2016 -- TikaMobile, Inc., a cloud-based mobile and analytics software provider for the life sciences industry, today announced that NeoTract, a developer of innovative, minimally invasive urology devices, will deploy TikaDevice across its sales force.
TikaDevice is TikaMobile’s CRM and data analytics platform for medical device launches. By enabling personalized recommendations and alerts on the latest available customer and product information, TikaDevice eliminates tedious preparation time for sales calls.
“By choosing TikaDevice, we’re confident that we’ve provided our sales team precisely what they need to target, inform and educate urologists across the country about the many advantages and benefits of the UroLift system,” said Dave Amerson, President and CEO of NeoTract, Inc.
“This is an exciting time for us at NeoTract, having just announced favorable clinical data and coverage decisions on our UroLift system,” Amerson continued. “We like that TikaDevice is easily customizable, and will save us both time and money. Last, but not least, TikaDevice can easily scale as we grow.”
“We’re honored to be chosen as the platform of choice by the NeoTract team to help execute sales and marketing strategy for their pioneering medical device system,” said Manish Sharma, chief executive officer at TikaMobile. “TikaDevice integrates CRM, ERP, and physician targeting capabilities into one mobile application with insights and recommendations. This will help NeoTract get real-time access to business intelligence, allowing them to scale with confidence.”
About TikaMobile
TikaMobile Inc. is leading innovations in cloud based mobile and analytics SaaS solutions for the life sciences industry. Dedicated to customer success, TikaMobile’s real time recommendation analytics go beyond CRM to give commercial and field sales teams ongoing actionable intelligence. Our powerful, yet agile applications for Medical Device and Pharmaceutical organizations are easy-to-use, easy-to-deploy, and can accommodate companies of all sizes. For more information visit us at www.tikamobile.com
Contact Cliona Barry [email protected]
